HIVClinicalForum
Meeting category
Date(s)
17 Aug 2022
Program Language
Portuguese, English
Location
Rio de Janeiro, Brazil
Meeting type
Live Meeting
Organizer

Rio de Janeiro HIV Clinical Forum 2022

Enduring Materials

The presentation videos and slides for speakers lectures will be made available shortly, provided that they have granted us permission to do so.

Session 1 | Antiretroviral Therapy 2022 - State of ART Plenary Lectures -
Highlights of IAS
Claudia Cortes, MD
University of Chile, Chile
Resistance Considerations in Choice of Regimen
Pablo Tebas, MD
University of Pennsylvania, United States of America
Pharmacological Considerations in Choice of Regimen
Ethel D. Weld, MD, PhD
Johns Hopkins University School of Medicine, United States of America
Toxicity & Adherence Considerations in Choice of Regimen
Maria Luisa Alcaide, MD, FIDSA
University of Miami Miller School of Medicine, United States of America
Session 2 | Starting and Switching Antiretroviral Therapy in 2022 -
Update on Therapeutic Options for Starting and Switching
Omar Sued, MSc, MD, PhD
Pan American Health Organization, United States
Considerations in Switching to Newer Regimens in Patients Suppressed on Older Drugs
Luis E. Soto-Ramírez, MD
Instituto Nacional de Ciencias Médicas y Nutrición, Mexico
HIV Treatment in Children - What Is New?
Cristina Barroso Hofer, MD, PhD
Federal University of Rio de Janeiro, Brazil
Session 3 | Long Acting Antiretrovirals for HIV Prevention and Treatment -
Update on HIV Prevention - The Latest on HPTN 083
Beatriz Grinsztejn, MD, PhD
Instituto de Pesquisa Clinica Evandro Chagas-Fiocruz, Brazil
Therapeutic Options for HIV Treatment for Cis/Trans Women
Romina Oliveira, MD
Instituto de Gestão Estratégica de Saúde do Distrito Federal, Brazil
Clinical Case
Marcio de Figueiredo Fernandes, MD
Universidade Federal do Rio de Janeiro, Brazil
Session 4 | Optimal Care for Underrepresented Populations -
Peculiarities for the Treatment and Prevention of HIV in the Elderly Patient
Richard Elion, MD
Washington Health Institute, United States
Current and Evolving Therapeutic Options for Patients with limited Treatment Options
Ricardo Diaz, MD
Federal University of Sao Paulo - UNIFESP, Brazil
Clinical Case
Tânia Vergara, MD, PhD
Sociedade de Infectologia do Rio de Janeiro, Brazil
Overview
Image
HCF_Rio
Welcome

The Rio de Janeiro HIV Clinical Forum 2022 provided an independent scientific program involving the world’s leading experts and was specifically designed for Brazilian HIV healthcare professionals, focusing on optimizing treatment for their patients. The meeting aimed to increase the knowledge and skills through lectures on novel treatment strategies, long-acting preparations, and the care of complex patients.

This program featured challenging plenary lectures followed by Q&A and debates, stimulating interactions, and the sharing of knowledge within the HIV-treating community. The program included networking opportunities for community building providing delegates with the unique opportunity to meet their colleagues in a focused and scientific setting.

The HIV Clinical Forum is a series of interactive programs that provide an independent scientific program on emerging topics in HIV involving experts where HIV clinicians and allied healthcare professionals receive updates on the latest developments related to comprehensive HIV management, where they can share their clinical experience and present the results from their ongoing and completed cohorts/ research programs.

Furthermore, the HIV Clinical Forum provides an educational setting where healthcare professionals can acquire specific skills that will enhance their capabilities to interpret research results and even develop new research projects. Maintaining these programs in a flexible format through the COVID-19 crisis is crucial for those living with HIV.

Program Director
Local Chair
General Information 
COVID-19 Update
The Rio de Janeiro HIV Clinical Forum 2022 was held as a live meeting.

We are available to answer any questions or concerns that you may have about your participation at the Rio de Janeiro HIV Clinical Forum 2022. For more information, please contact Ms. Natalia Voronina at natalia.voronina@amededu.com.

To stay updated on developments about this meeting, make sure that you are signed up for our newsletter.
Who Should Attend?
- Primary: medical doctors involved in the management and treatment of people living with HIV in the region
- Secondary: researchers
- Tertiary: healthcare workers, clinical virologists, microbiologists, scientists, pharmacologists, nurses, post-doctoral researchers, students, and other healthcare professionals involved in treating people living with HIV
Meeting Objectives
With the HIV Clinical Forum program we aim to:

- Build a community of healthcare professionals devoted to providing optimal clinical care for their patients
- Create a platform for interactive information exchange on novel treatment strategies and options
- Translate the latest studies and research achievements into clinical guidance for the optimal management of people living with HIV
Learning Objectives
After participating in the HIV Clinical Forum, participants will be able to:

- Understand the scientific rationale and clinical data supporting novel treatment strategies
- Describe the pros and cons of novel treatment strategies and drugs
- Understand how to integrate novel treatment strategies into routine patient care
- Be knowledgeable of the clinical data supporting long-acting injectable regimens
- Identify patients who might most benefit from long-acting injectable regimens
- Gain knowledge on how to optimally integrate injectable drugs into routine clinical care
- Improve their skills in defining and identifying treatment experienced people living with HIV
- Stay informed on new drug options for treatment experienced people living with HIV
- Understand how best to use new treatment options for highly treatment experienced people living with HIV
Code of Conduct
All attendees, speakers, co-organizers, partners, endorsers, suppliers, volunteers, and employees at any of our programs are expected to observe our Code of Conduct. We cannot tolerate any form of discrimination, harassment, disrespect, or the marginalization of those involved in our programs. All participants of VE and AME-organized programs are expected to treat others with dignity and respect at all times.

Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE and AME via info@amededu.com or to one of our on-site personnel.

Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.
Practical Information 
Certificate of Attendance
A certificate of attendance will be sent by e-mail shortly after the forum meeting.
Disclaimer
This conference is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this event, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this meeting. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the conference.
Language
The official language of this meeting is Portuguese. English translation will be available.
Liability and Insurance
By registering for the conference participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
Meeting Materials
An official program and speakers' bios will be sent by e-mail prior to the meeting.
Photographs, Audio, and Video Recording
Photographs, audio, and video recordings are not permitted at the official meeting sessions. Only the official medical writer appointed by the organization may make recordings. All presentations will be posted here as soon as possible after the workshop is finished, provided the speaker has given permission to do so.
Committees
Program Director
Local Chair
Support

The Rio de Janeiro HIV Clinical Forum 2022 is supported by an independent educational grant from ViiV Healthcare.

ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity.

Meeting Partner
Endorsers
Previous Editions
Language
Ratings previous edition
Content is relevant to my practice
4.5
(119)
Content was free from commercial bias
4.0
Overall event experience
4.4